Ignite Creation Date:
2025-12-24 @ 1:29 PM
Ignite Modification Date:
2026-01-29 @ 1:22 AM
Study NCT ID:
NCT03896295
Status:
TERMINATED
Last Update Posted:
2023-06-27
First Post:
2019-03-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis
Sponsor:
Momenta Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-06
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-09
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-28
First Submit QC Date:
None
Study First Post Date:
2019-03-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-12-07
Results First Submit QC Date:
None
Results First Post Date:
2022-02-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-07
Last Update Post Date:
2023-06-27
Last Update Post Date Type:
ACTUAL